Hyundai Bioscience presents clinical strategy for antiviral drug 'Jepti' in the US
Predicted impact: Low
Clinical strategy presentation already reported in recent days at the same US conference; no new data.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.